McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025.

Revenue
+7.57%
EPS
+17.0%
Free cash flow
+32.5%
Total debt
+7.08%

Quarter to September 2026, against a year earlier

1,061.69 10.31 −0.96%
Market cap
$125.0B
P/E
27.5×
Fwd P/E
25.4×
Dividend yield
0.32%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100
Sep '26 From the 10-Q filed 4 Nov Jun '26 Mar '26 Dec '25 Older periods
Piotroski F-Score
7 7 7 7

+8 more TTM periods

ROE
(190.51%) (168.45%) (274.39%) (240.78%)
ROA
5.33% 5.41% 6.05% 5.59%
ROIC
114.15% 70.49% 66.20% 45.30%
Return on Tangible Assets
(93.14%) (94.97%) (66.70%) (74.83%)
Average Days of Receivables
26.85 26.92 25.32 25.88
Free Cash Flow per Share
59.05 51.77 43.77 78.28
Free Cash Flow
6,868.00 6,145.00 5,410.00 9,644.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 4 Nov 2026